pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 18·1 min read
save

Opinion warns US surrogacy system is chaotic and may face bans after decades of legal battles

Aug 18, 2026·read at STAT ↗Negative

Arthur Caplan writes that the United States surrogacy framework is poorly managed, using the recent West case as a warning sign. He argues that the lack of clear rules could lead to broader bans.

The story references the 1986 incident involving Mary Beth Whitehead, who agreed to carry a child for a couple in exchange for $10,000, then fled with the baby to Florida, sparking a high‑profile custody fight.

The New Jersey Supreme Court ruled in 1988 that surrogacy contracts were void, returning parental decisions to family courts and ultimately granting custody to the intended parents.

Four decades later, Caplan says the system remains largely unregulated and ethically fraught, prompting calls for reform before stricter regulations or bans are imposed globally.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: 8 steps to making surrogacy more ethical for everyone involved”

read at STAT ↗
1,182 words · retrieved Aug 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
HERITAGEOVERSEASUltragenyx Pharmaceutical Inc.
topics
Cardiology3Rare DiseaseVaccines

related stories

  • Jun 6Opinion: How the Amish think about vaccines, health care costs, and much moreSTAT
  • 1d agoNovo, BioMarin, Enanta dole out pink slipsBioSpace
  • Aug 12STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts saySTAT
  • Aug 12STAT+: Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health careSTAT
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT